| Mrs June Goodman Kessler, CCC-SLP;MS | |
|
11909 Berans Rd, Lutherville, MD 21093-1522 | |
| (410) 913-5121 | |
| (410) 561-1905 |
| Full Name | Mrs June Goodman Kessler |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 11909 Berans Rd, Lutherville, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528387537 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 04277 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs June Goodman Kessler, CCC-SLP;MS 11909 Berans Rd, Lutherville, MD 21093-1522 Ph: (410) 913-5121 | Mrs June Goodman Kessler, CCC-SLP;MS 11909 Berans Rd, Lutherville, MD 21093-1522 Ph: (410) 913-5121 |
News Archive
There is a very high prevalence of osteopenia/osteoporosis among male patients with pulmonary disease, according to a new study from researchers in California.
Mayo Clinic researchers have shown why, in a minority of HIV patients, immune function improves despite a lack of response to standard anti-retroviral treatment. In these cases, researchers say, the virus has lost its ability to kill immune cells. The findings appear in the online journal PLoS Pathogens.
The "gold standard" diabetes test, Hemoglobin A1c (A1C), explains much less about the risk of cardiovascular complications in patients with diabetes than originally thought, according to an article in the June 9 issue of the Journal of the American Medical Association (JAMA). The article entitled, "Beyond HbA1c: Need for Additional Markers of Risk for Diabetic Microvascular Complications," was co-authored by Irl Hirsch, M.D., of the University of Washington Medical School (Seattle, WA) and Michael Brownlee, M.D., of the Albert Einstein College of Medicine.
A new approach to controlling blood cholesterol levels that is already being investigated to prevent cardiovascular disease also may be a potential treatment for Alzheimer's disease.
Gilead Sciences, Inc. announced today plans to launch authorized generic versions of Epclusa and Harvoni, Gilead's leading treatments for chronic hepatitis C virus, in the United States, through a newly created subsidiary, Asegua Therapeutics LLC.
› Verified 4 days ago
Courtney Caplan, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25 Faraday Dr, Lutherville, MD 21093 Phone: 410-591-5082 | |
Jenna Persio, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 515 Brightfield Rd, Lutherville, MD 21093 Phone: 443-695-4050 | |
Annette Z Dow, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1818 Pot Spring Rd, Suite 30, Lutherville, MD 21093 Phone: 410-583-5765 | |
Melissa Ott, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 515 Brightfield Rd, Lutherville, MD 21093 Phone: 410-832-2398 Fax: 410-296-3654 | |
Bonnie Zentz, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1818 Pot Spring Rd, Suite 100, Lutherville, MD 21093 Phone: 410-583-5765 | |
Sarah Elizabeth Kinhart, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8 Belmullet Ct Unit 301, Lutherville, MD 21093 Phone: 410-812-6059 | |
Lorraine Lodge, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1818 Pot Spring Rd, Lutherville, MD 21093 Phone: 410-583-5765 |